CONTER, VALENTINO
 Distribuzione geografica
Continente #
NA - Nord America 2.867
EU - Europa 1.471
AS - Asia 725
SA - Sud America 61
Continente sconosciuto - Info sul continente non disponibili 8
AF - Africa 5
OC - Oceania 3
Totale 5.140
Nazione #
US - Stati Uniti d'America 2.834
SG - Singapore 329
RU - Federazione Russa 298
IT - Italia 275
SE - Svezia 215
DE - Germania 214
CN - Cina 200
IE - Irlanda 146
HK - Hong Kong 86
GB - Regno Unito 60
AT - Austria 51
BR - Brasile 45
UA - Ucraina 42
FR - Francia 40
FI - Finlandia 39
VN - Vietnam 34
CA - Canada 28
ID - Indonesia 22
DK - Danimarca 19
TR - Turchia 17
NL - Olanda 16
BE - Belgio 13
IN - India 10
AR - Argentina 9
PL - Polonia 9
BD - Bangladesh 6
EU - Europa 6
PT - Portogallo 6
GR - Grecia 5
KR - Corea 5
PE - Perù 5
CZ - Repubblica Ceca 4
ES - Italia 4
RO - Romania 4
AU - Australia 3
CH - Svizzera 3
GT - Guatemala 3
NO - Norvegia 3
BG - Bulgaria 2
CY - Cipro 2
EC - Ecuador 2
EG - Egitto 2
IQ - Iraq 2
IR - Iran 2
MX - Messico 2
PH - Filippine 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AP - ???statistics.table.value.countryCode.AP??? 1
BA - Bosnia-Erzegovina 1
DZ - Algeria 1
IL - Israele 1
JP - Giappone 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 5.140
Città #
Ann Arbor 677
Fairfield 242
Singapore 221
Chandler 219
Woodbridge 171
Wilmington 168
Ashburn 157
Dublin 145
Frankfurt am Main 145
Houston 137
Seattle 107
Cambridge 89
Dearborn 86
Hong Kong 86
New York 84
Milan 78
Santa Clara 66
Princeton 52
Vienna 45
Jacksonville 43
Nanjing 32
Altamura 28
Lawrence 26
Shanghai 24
Jakarta 22
Rome 22
Helsinki 21
Grafing 20
Moscow 20
Beijing 17
Dong Ket 15
Guangzhou 15
San Diego 15
Boardman 13
London 13
Brussels 10
Nanchang 10
Turin 10
Los Angeles 9
Paris 9
Toronto 9
Council Bluffs 8
Lissone 8
Sulmona 8
Andover 7
Hefei 7
Kunming 7
Mountain View 7
Perugia 7
Shenyang 7
Turku 7
Chicago 6
Lachine 6
Ottawa 6
Warsaw 6
Bonndorf 5
Edmonton 5
Lisbon 5
Monza 5
Nuremberg 5
São Paulo 5
Zhengzhou 5
Athens 4
Belo Horizonte 4
Besana In Brianza 4
Bologna 4
Changsha 4
Hangzhou 4
Jinan 4
Naples 4
Buenos Aires 3
Catania 3
Como 3
Desio 3
Düsseldorf 3
Edinburgh 3
Fuzhou 3
Gaithersburg 3
Gap 3
Hebei 3
Leawood 3
Lima 3
Munich 3
Norwalk 3
Oslo 3
Pune 3
Redmond 3
Rho 3
Stockholm 3
Tianjin 3
Americana 2
Amsterdam 2
Boston 2
Brasília 2
Brno 2
Campobasso 2
Cedar Knolls 2
Cinisello Balsamo 2
Copperas Cove 2
Daejeon 2
Totale 3.622
Nome #
Predictive value of minimal residual disease in philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies 308
Reduced-Intensity delayed intensification in standard-Risk pediatric acute lymphoblastic leukemia defined by undetectable minimal residual disease: Results of an international randomized trial (AIEOP-BFM ALL 2000) 259
Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study 255
Oral nutritional supplementation in children treated for cancer in low- and middle-income countries is feasible and effective: The experience of the children's hospital manuel de jesus rivera "la mascota" in Nicaragua 249
Autologous Purified Peripheral Blood Stem Cell Transplantation Compare to Chemotherapy in Childhood Acute Lymphoblastic Leukemia after Low-Risk Relapse 231
The treatment of childhood acute lymphoblastic leukemia in Guatemala: Biologic features, treatment hurdles, and results 213
Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: High white blood cell count at diagnosis is the strongest prognostic factor 210
Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati 207
Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: An international collaborative study 206
Pharmacodynamic effects in the cerebrospinal fluid of rats after intravenous administration of different asparaginase formulations 206
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000 193
Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL 189
Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention? 185
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants 179
Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: A retrospective analysis 175
Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial 171
CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemia 169
The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols 159
Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial 150
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols 144
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120 143
Validation of Minimal Residual Disease as Surrogate Endpoint for Event-Free Survival in Childhood Acute Lymphoblastic Leukemia 142
Droplet Digital PCR Improves IG-/TR-based MRD Risk Definition in Childhood B-cell Precursor Acute Lymphoblastic Leukemia 136
Musculoskeletal manifestations of childhood cancer and differential diagnosis with juvenile idiopathic arthritis (ONCOREUM): a multicentre, cross-sectional study 126
Postinduction minimal residual disease monitoring by polymerase chain reaction in children with acute lymphoblastic leukemia 124
Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10–14 years as compared with those aged 15–17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study 123
Osteonecrosis in paediatric acute lymphoblastic leukaemia: Incidence, risk factors, radiological patterns and evolution in a single-centre cohort 90
FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD) 83
Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease 77
A Hematopoietic Stem Cell Transplantation Startup in Iraqi Kurdistan: Results in Thalassemia Patients and Analysis of the Methodology 74
Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia 62
Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome 56
Eight-year national multicenter experience on the use of glucarpidase as effective rescue therapy for delayed methotrexate elimination after high-dose methotrexate cycles administered in children with hemato-oncological diseases 26
Totale 5.320
Categoria #
all - tutte 20.461
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.461


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202058 0 0 0 0 0 0 0 0 0 0 44 14
2020/2021884 54 99 95 74 47 89 75 89 61 53 68 80
2021/2022484 51 55 66 44 23 52 15 23 35 20 42 58
2022/2023867 88 262 50 85 46 132 15 77 53 2 47 10
2023/2024516 26 16 24 60 64 129 107 26 13 6 5 40
2024/20251.160 56 158 98 80 127 46 63 29 170 206 127 0
Totale 5.320